Artificial intelligence and data analytics are increasingly valuable tools for pharma companies, enabling them to accelerate clinical trials and unlock the value of products earlier. As data applications become more advanced, the whole healthcare value chain could be affected. New forms of drug discovery will emerge and pharma workforces will need to evolve. At the same time, the collection of real-world evidence using AI platforms will alter the role of patients.
Join us at the FT Pharma AI and Data Summit in Boston on March 4, 2021, to find out how artificial intelligence and data analytics can be deployed effectively in drug discovery, clinical trials, market access and other areas. Gain valuable insights into the opportunities and risks different stakeholders may face in the age of AI, where everything is defined by data.